BioInsights - Reliable & scalable EuLV<sup>®️</sup> stable LVV production system

Reliable & scalable EuLV®️ stable LVV production system

Cell and Gene Therapy Insights 2023; 9(2), 194;

DOI: 10.18609/cgti.2023.028

Published: 8 March 2023
Roy Bin Liu

Watch the video or read the poster to learn about:

  • LVV production based on stable producer cell lines
  • Automated monoclonal cell screening system EuBioX
  • Utilizing HEK293T inducible stable producer cells lines to produce LLV in high-density suspension culture
  • A case study of the EuLV producer cell line development process

Mr Liu graduated from the Hong Kong University of Science and Technology with Master degree in Biotechnology. He previously worked in Bio-techne and InvivoGen. Mr Liu joined EurekaBio in 2016 as COO, and has extensive knowledge in Gene and Cell therapy industry, and is experienced in business development, project management, process development, cGMP etc.